image
Viridian Therapeutics, Inc. VRDN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 20.14
-6.93 %
$ 1.6 B
Market Cap
-4.66
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -82.28% -89.51% -89.46%
Annual Report FY 10-K 2022-12-31 -40.20% -57.96% -68.45%
Annual Report FY 10-K 2021-12-31 182.19% 28.44% 27.77%
Annual Report FY 10-K 2020-12-31 -76.46% -161.63% -162.94%
Annual Report FY 10-K 2019-12-31 -46.80% -29.71% -26.89%
Annual Report FY 10-K 2018-12-31 109.49% -23.35% -24.69%
Annual Report FY 10-K 2017-12-31 19.96% -109.18% -112.12%
Annual Report FY 10-K 2016-12-31 31.48% -11.88% -11.81%
Annual Report FY 10-K 2015-12-31 -41.25% -43.57% -62.91%
Annual Report FY 10-K 2014-12-31 0.08% -265.33% -3399.77%
Annual Report FY 10-K 2013-12-31 -2.03% 70.05% 95.13%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 19.44% -60.91% -62.97%
Quarterly Report Q2 8-K 2024-06-30 0.00% -18.03% -21.78%
Quarterly Report Q1 8-K 2024-03-31 -26.53% 28.66% 22.87%
Quarterly Report Q4 8-K 2023-12-31 -31.43% -57.30% -45.68%
Quarterly Report Q3 8-K 2023-09-30 -93.97% -70.06% -71.98%
Quarterly Report Q2 8-K 2023-06-30 -71.88% -86.71% -100.50%
Quarterly Report Q1 8-K 2023-03-31 -54.63% -166.88% -179.94%
Quarterly Report Q4 8-K 2022-12-31 -50.93% -46.84% -68.72%
Quarterly Report Q3 8-K 2022-09-30 474.52% -99.57% -110.73%
Quarterly Report Q2 8-K 2022-06-30 -76.51% -64.17% -64.26%
Quarterly Report Q1 8-K 2022-03-31 -85.11% -38.12% -39.83%
Quarterly Report Q4 8-K 2021-12-31 296.30% 68.10% 67.90%
Quarterly Report Q3 8-K 2021-09-30 0.00% -155.61% -161.26%
Quarterly Report Q2 8-K 2021-06-30 548.81% -179.16% -182.37%
Quarterly Report Q1 8-K 2021-03-31 75.24% -129.49% -131.50%
Quarterly Report Q4 8-K 2020-12-31 -93.86% -796.84% -799.59%
Quarterly Report Q3 8-K 2020-09-30 0.00% 51.08% 51.83%
Quarterly Report Q2 8-K 2020-06-30 -93.32% 27.66% 28.72%
Quarterly Report Q1 8-K 2020-03-31 122.58% 30.83% 31.85%
Quarterly Report Q4 8-K 2019-12-31 84.87% 1.93% 3.65%
Quarterly Report Q3 8-K 2019-09-30 -26.38% -24.63% -22.72%
Quarterly Report Q2 8-K 2019-06-30 15.22% -2.09% -0.91%
Quarterly Report Q1 8-K 2019-03-31 -92.22% -149.50% -154.08%
Quarterly Report Q4 8-K 2018-12-31 -60.07% -61.56% -64.51%
Quarterly Report Q3 8-K 2018-09-30 -42.12% -54.46% -55.39%
Quarterly Report Q2 8-K 2018-06-30 203.90% -19.17% -20.56%
Quarterly Report Q1 8-K 2018-03-31 935.50% 33.22% 33.43%
Quarterly Report Q4 8-K 2017-12-31 57.67% -14.65% -16.10%
Quarterly Report Q3 8-K 2017-09-30 83.46% -217.24% -224.28%
Quarterly Report Q2 8-K 2017-06-30 -17.85% -191.66% -195.89%
Quarterly Report Q1 8-K 2017-03-31 -43.52% -153.08% -153.71%
Quarterly Report Q4 8-K 2016-12-31 14.72% -86.91% -85.09%
Quarterly Report Q3 8-K 2016-09-30 77.45% 41.66% 41.94%
Quarterly Report Q2 8-K 2016-06-30 19.07% 2.15% 0.24%
Quarterly Report Q1 8-K 2016-03-31 26.82% -4.71% -4.71%
Quarterly Report Q4 8-K 2015-12-31 0.69% -31.97% -31.08%
Quarterly Report Q3 8-K 2015-09-30 -61.49% -92.52% -91.54%
Quarterly Report Q2 8-K 2015-06-30 -42.37% 22.10% 11.43%
Quarterly Report Q1 8-K 2015-03-31 -40.88% -273.20% -1466.95%
Quarterly Report Q4 8-K 2014-12-31 -39.99% -1011.33% -884.41%
Quarterly Report Q3 8-K 2014-09-30 32.27% -86.12% -423.99%
Quarterly Report Q2 8-K 2014-06-30 15.47% -509.41% -4556.70%
Quarterly Report Q1 8-K 2014-03-31 -4.25% -31.39% -110.33%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%